Cargando…
Vall d’Hebron Risk Score II for myocardial infarction and cardiac death
OBJECTIVES: The aim of this study was to create a new Vall d’Hebron Risk Score-II (VH-RS-II) for non-fatal myocardial infarction (MI) and/or cardiac death (CD), excluding patients with coronary revascularisation (CR) during the follow-up. METHODS: We analysed 5215 consecutive patients underwent gate...
Autores principales: | Romero-Farina, Guillermo, Aguadé-Bruix, Santiago, Ferreira González, Ignacio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632909/ https://www.ncbi.nlm.nih.gov/pubmed/37935561 http://dx.doi.org/10.1136/openhrt-2023-002431 |
Ejemplares similares
-
End of Life Intervention Program During COVID-19 in Vall d'Hebron University Hospital
por: Beneria, Anna, et al.
Publicado: (2021) -
Patient-oriented risk score for predicting death 1 year after myocardial infarction: the SweDen risk score
por: Rylance, Rebecca Tremain, et al.
Publicado: (2022) -
Interphysician agreement on subclassification of myocardial infarction
por: Gard, Anton, et al.
Publicado: (2018) -
Association of hyperlipidaemia with 5-year survival after hospitalisation for acute myocardial infarction: a propensity score matched analysis
por: Yousufuddin, Mohammed, et al.
Publicado: (2020) -
Creatine kinase is associated with bleeding after myocardial infarction
por: Brewster, Lizzy Maritza, et al.
Publicado: (2020)